Vacation coronary heart: The overindulgences all through competition season that put even wholesome other folks in peril

Source link : https://health365.info/vacation-coronary-heart-the-overindulgences-all-through-competition-season-that-put-even-wholesome-other-folks-in-peril/ Credit score: Unsplash/CC0 Public Area Competition season will also be unusually bodily hard. Hours spent status, strolling or dancing can put additional pressure at the coronary heart, particularly for the ones…

Learn about displays sharp contrasts in complementary and replacement treatment use throughout international locations

Source link : https://health365.info/learn-about-displays-sharp-contrasts-in-complementary-and-replacement-treatment-use-throughout-international-locations/ Credit score: Unsplash/CC0 Public Area Opposite to expectancies, the COVID pandemic didn’t purpose a spike within the total use of complementary and replacement treatment (CAM) in Europe: the expansion was once…

Lone Passenger Survives the Deadly Air India Crash

Source link : https://newshealth.biz/health-news/lone-passenger-survives-the-deadly-air-india-crash/ (MedPage Today) — The lone passenger to survive the Air India crash that killed at least 240 people Thursday found himself near debris after being thrown out of the plane and…

The hidden warmth disaster: File reveals pressing want for office protections indoors

Source link : https://health365.info/the-hidden-warmth-disaster-file-reveals-pressing-want-for-office-protections-indoors/ Frequency of Indoor Temperatures Over 80°F at Paintings all the way through Summer season by means of Subsectors. Credit score: https://shift.hks.harvard.edu/wp-content/uploads/2025/06/Heat_Report_Final.pdf The file, launched by means of the Shift Venture—a joint…

Non-Surgical Option Approved for Recurrent Low-Grade Bladder Cancer

Source link : https://newshealth.biz/health-news/non-surgical-option-approved-for-recurrent-low-grade-bladder-cancer/ (MedPage Today) — The FDA approved mitomycin intravesical solution (Zusduri) as a nonsurgical option for recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC). The product won the indication despite a negative…